Search research articles
Contact Us
Filters
Showing results (131-140 of 531) with videos related to
Page
of 54
Sort By:
Clinical Pharmacy
|
February 1, 1989
Enoxacin: a new fluoroquinolone
L A Jaber, E M Bailey, M J Rybak
Journal of the American Chemical Society
|
October 17, 2024
Dinickel-Catalyzed N=N Coupling Reactions for the Synthesis of Hindered Azoarenes
Christopher J Rybak, Chengyi Fan, Parijat Sharma, et al.
Infectious Diseases and Therapy
|
February 3, 2016
Oritavancin: A New Lipoglycopeptide Antibiotic in the Treatment of Gram-Positive Infections
Karrine D Brade, Jeffrey M Rybak, Michael J Rybak
Pharmacotherapy
|
October 27, 2015
Dalbavancin and Oritavancin: An Innovative Approach to the Treatment of Gram-Positive Infections
Karrine D Roberts, Rand M Sulaiman, Michael J Rybak
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 9, 2019
Delafloxacin in Acute Bacterial Skin and Skin Structure Infections
G Ralph Corey, Jamie A McKinnell, Michael J Rybak
Drug Intelligence & Clinical Pharmacy
|
June 1, 1984
Sensitivity testing and the inoculum effect
S R Erickson, S A Hunt, M J Rybak
Antimicrobial Agents and Chemotherapy
|
January 27, 2006
Pulsatile delivery of clarithromycin alone or in combination with amoxicillin against Streptococcus pneumoniae
Kimberly D Leuthner, Chrissy M Cheung, Michael J Rybak
The Annals of Pharmacotherapy
|
May 1, 1994
Oral treatment of gonorrhea and chlamydia
K A Loughlin, C M Bakst, M J Rybak
Antimicrobial Agents and Chemotherapy
|
September 1, 1993
Pharmacodynamic effects of extended dosing intervals of imipenem alone and in combination with amikacin against Pseudomonas aeruginosa in an in vitro model
B J McGrath, K C Lamp, M J Rybak
Antimicrobial Agents and Chemotherapy
|
May 17, 2001
Activities of newer fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae
E A Coyle, G W Kaatz, M J Rybak
Page
of 54
Search research articles
Search
Showing results (131-140 of 531) with videos related to
Sort By:
Page
of 54
Clinical Pharmacy
|
February 1, 1989
Enoxacin: a new fluoroquinolone
L A Jaber, E M Bailey, M J Rybak
Journal of the American Chemical Society
|
October 17, 2024
Dinickel-Catalyzed N=N Coupling Reactions for the Synthesis of Hindered Azoarenes
Christopher J Rybak, Chengyi Fan, Parijat Sharma, et al.
Infectious Diseases and Therapy
|
February 3, 2016
Oritavancin: A New Lipoglycopeptide Antibiotic in the Treatment of Gram-Positive Infections
Karrine D Brade, Jeffrey M Rybak, Michael J Rybak
Pharmacotherapy
|
October 27, 2015
Dalbavancin and Oritavancin: An Innovative Approach to the Treatment of Gram-Positive Infections
Karrine D Roberts, Rand M Sulaiman, Michael J Rybak
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 9, 2019
Delafloxacin in Acute Bacterial Skin and Skin Structure Infections
G Ralph Corey, Jamie A McKinnell, Michael J Rybak
Drug Intelligence & Clinical Pharmacy
|
June 1, 1984
Sensitivity testing and the inoculum effect
S R Erickson, S A Hunt, M J Rybak
Antimicrobial Agents and Chemotherapy
|
January 27, 2006
Pulsatile delivery of clarithromycin alone or in combination with amoxicillin against Streptococcus pneumoniae
Kimberly D Leuthner, Chrissy M Cheung, Michael J Rybak
The Annals of Pharmacotherapy
|
May 1, 1994
Oral treatment of gonorrhea and chlamydia
K A Loughlin, C M Bakst, M J Rybak
Antimicrobial Agents and Chemotherapy
|
September 1, 1993
Pharmacodynamic effects of extended dosing intervals of imipenem alone and in combination with amikacin against Pseudomonas aeruginosa in an in vitro model
B J McGrath, K C Lamp, M J Rybak
Antimicrobial Agents and Chemotherapy
|
May 17, 2001
Activities of newer fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae
E A Coyle, G W Kaatz, M J Rybak
Page
of 54